When is OTLK's latest earnings report released?
The most recent financial report for Outlook therapeutics, inc. (OTLK) covers the period of 2026Q1 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating OTLK's short-term business performance and financial health. For the latest updates on OTLK's earnings releases, visit this page regularly.
What is the operating profit of OTLK?
According to the latest financial report, Outlook therapeutics, inc. (OTLK) reported an Operating Profit of -13.48M with an Operating Margin of 1,116.38% this period, representing a growth of 37.59% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is OTLK's revenue growth?
In the latest financial report, Outlook therapeutics, inc. (OTLK) announced revenue of -1.21M, with a Year-Over-Year growth rate of 0%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does OTLK have?
As of the end of the reporting period, Outlook therapeutics, inc. (OTLK) had total debt of 36.89M, with a debt ratio of 2.02. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does OTLK have?
At the end of the period, Outlook therapeutics, inc. (OTLK) held Total Cash and Cash Equivalents of 8.68M, accounting for 0.48 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does OTLK go with three margins increasing?
In the latest report, Outlook therapeutics, inc. (OTLK) achieved the “three margins increasing” benchmark, with a gross margin of 102.5%%, operating margin of 1,116.38%%, and net margin of 1,909%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess OTLK's profit trajectory and future growth potential.
Is OTLK's EPS continuing to grow?
According to the past four quarterly reports, Outlook therapeutics, inc. (OTLK)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.38. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of OTLK?
Outlook therapeutics, inc. (OTLK)'s Free Cash Flow (FCF) for the period is -14.94M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 36.21% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
